Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W LUTZ

Showing results (521-530 of 538) with videos related to

Pageof 54
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPatrick J Smith, Kim G Johnson, Heidi L Roth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPatrick J Smith, Kim G Johnson, Heidi L Roth, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 28, 2015
APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleedsDonald M Lyall, Susana Muñoz Maniega, Sarah E Harris, et al.
Plos One|November 22, 2013
Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936Donald M Lyall, Natalie A Royle, Sarah E Harris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPatrick J Smith, Kim G Johnson, Heidi L Roth, et al.
Translational Psychiatry|September 24, 2014
Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?D M Lyall, S E Harris, M E Bastin, et al.
Neurobiology of Aging|February 11, 2014
Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936Donald M Lyall, Sarah E Harris, Mark E Bastin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differencesE Keats Shwab, Gita A Pathak, Joshua Harvey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2014
African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian allelesAllen D Roses, Michael W Lutz, Ann M Saunders, et al.
The Lancet. Neurology|June 19, 2021
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trialDaniel K Burns, Robert C Alexander, Kathleen A Welsh-Bohmer, et al.
Pageof 54

Showing results (521-530 of 538) with videos related to

Sort By:
Pageof 54
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPatrick J Smith, Kim G Johnson, Heidi L Roth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPatrick J Smith, Kim G Johnson, Heidi L Roth, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 28, 2015
APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleedsDonald M Lyall, Susana Muñoz Maniega, Sarah E Harris, et al.
Plos One|November 22, 2013
Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936Donald M Lyall, Natalie A Royle, Sarah E Harris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersPatrick J Smith, Kim G Johnson, Heidi L Roth, et al.
Translational Psychiatry|September 24, 2014
Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?D M Lyall, S E Harris, M E Bastin, et al.
Neurobiology of Aging|February 11, 2014
Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936Donald M Lyall, Sarah E Harris, Mark E Bastin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differencesE Keats Shwab, Gita A Pathak, Joshua Harvey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2014
African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian allelesAllen D Roses, Michael W Lutz, Ann M Saunders, et al.
The Lancet. Neurology|June 19, 2021
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trialDaniel K Burns, Robert C Alexander, Kathleen A Welsh-Bohmer, et al.
Pageof 54